Fred A. Middleton - Oct 28, 2024 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role
Director
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Stock symbol
CMRX
Transactions as of
Oct 28, 2024
Transactions value $
$0
Form type
4
Date filed
10/30/2024, 08:00 PM
Previous filing
Aug 28, 2024
Next filing
Nov 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock Gift $0 -60K -60% $0.00 40K Oct 28, 2024 Fred A. Middleton Separate Property Trust F1
holding CMRX Common Stock 60K Oct 28, 2024 Middleton Childrens 2015 Irrevocable Trust F1
holding CMRX Common Stock 208K Oct 28, 2024 Direct
holding CMRX Common Stock 2.78M Oct 28, 2024 See footnote F2, F3
holding CMRX Common Stock 532K Oct 28, 2024 See footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 28, 2024, the Reporting Person transferred 60,000 shares of the Company's common stock to Middleton Childrens 2015 Irrevocable Trust for no consideration. The Reporting Person is trustee of the trust and members of his immediate family are beneficiaries of the trust. The Reporting Person remains the beneficial owner of the securities held by the trust.
F2 The securities are held as follows: 829,046 shares of common stock held by Sanderling Venture Partners V, L.P., 233,134 shares of common stock held by Sanderling V Biomedical, L.P., 155,143 shares of common stock held by Sanderling V Limited Partnership, 138,046 shares of common stock held by Sanderling V Beteiligungs GmbH & Co. KG, 199,853 shares of common stock held by Sanderling V Biomedical Co-Investment Fund, L.P., 329,682 shares of common stock held by Sanderling Venture Partners V Co-Investment Fund, L.P. and 891,189 shares of common stock held by Sanderling V Strategic Exit Fund, L.P. (collectively, the Sanderling V Shares).
F3 The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling V Shares and the Sanderling VI Shares (as defined herein). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F4 The securities are held as follows: 498,046 shares of common stock held by Sanderling Venture Partners VI Co-Investment Fund, L.P., 15,431 shares of common stock held by Sanderling VI Beteiligungs GmbH & Co. KG and 18,384 shares of common stock held by Sanderling VI Limited Partnership (collectively, the Sanderling VI Shares).